Glaucoma Fast Track 2022
Glaucoma Fast Track 2022
May 24, 2022
Description
BrightFocus Foundation will hold the third Glaucoma Fast Track to accelerate the fight for a cure by investing in promising young scientists in the field of vision research.
This year, speakers have been asked to refer as needed to videos of previous Glaucoma Fast Tracks in order to concentrate on new insights, pitfalls to avoid, unanswered/future questions and areas of opportunity. Therefore, all 2022 attendees are strongly encouraged to view the 2017 and 2019 videos prior to attending this year’s Fast Track.
- View videos of past Glaucoma Fast Track workshop presentations:
- Learn more about the Fast Track workshop in our Science News article, "Glaucoma Fast Track: Investing in the Future."
Please read about our COVID Safety Guidelines
ISER/BrightFocus Glaucoma Symposium Website
May 24, 2022
Emory Conference Center
1615 Clifton Road
Atlanta, Georgia, USA
Co-Organizers & Co-Chairs
Graduate students, postdoctoral fellows, or other early-stage scientists focused on glaucoma research, or those who want to enter the field, took advantage of this unique opportunity to accelerate their path towards becoming an expert in this exciting field by:
- immersing themselves in the background knowledge and latest discoveries in glaucoma research
- connecting with preeminent glaucoma experts and fellow early-stage researchers based in the U.S. and around the world
- engaging in scientific debates
(On mobile devices, you may need to swipe left to see all of the table columns below.)
| TIME | TOPIC | SPEAKER |
|---|---|---|
|
7:45 am |
Introduction of BrightFocus Glaucoma Fast Track Introduction of Fast Track Speakers |
Preeti Subramanian, PhD, BrightFocus Foundation John Morrison, MD, Oregon Health and Science University |
|
8:00 am |
Clinical Glaucoma |
Leon Herndon, MD |
|
8:25 am |
Epidemiology and Public Health Impact of Glaucoma |
Anne Coleman, MD, PhD |
|
8:50 am |
Q and A |
|
|
9:00 am |
Human Glaucoma Genetics |
Michael Hauser, PhD |
|
9:25 am |
Glaucoma Therapeutics in the Pipeline and the Future |
Kate Bollinger, MD |
|
9:50 am |
Q and A |
|
|
10:00 am |
Break |
|
|
10:30 am |
OCT in the diagnosis and management of glaucoma |
Joel Schuman, MD |
|
10:55 am |
New OCT developments and application to experimental glaucoma |
Yali Jia, PhD |
|
11:20 am |
Q and A |
|
|
11:30 am |
Lunch |
|
|
12:30 pm |
Biomechanics of ONH injury in glaucoma |
Vicky Nguyen, PhD |
|
12:55 pm |
Biomechanics of outflow dysfunction in glaucoma |
Mark Johnson, PhD |
|
1:20 pm |
Q and A |
|
|
1:30 pm |
Inducible rodent models of glaucomatous optic nerve damage |
Colleen McDowell, PhD |
|
1:55 pm |
Non-rodent models of glaucomatous optic nerve damage |
Gillian McLellan, PhD |
|
2:20 pm |
Q and A |
|
|
2:30 pm |
Break |
|
|
3:00 pm |
Mechanisms of axonal injury in experimental glaucoma |
Denise Inman, PhD |
|
3:25 pm |
RGC Injury in Glaucoma |
Richard Libby, PhD |
|
3:50 pm |
Q and A |
|
|
4:00 pm |
Experimental models to study trabecular meshwork pathology |
Abe Clark, PhD |
|
4:25 pm |
Cross-talk between glaucoma pathogenic signaling pathways in the TM |
Weiming Mao, PhD |
|
4:50 pm |
Q and A |
|
|
5:00 pm |
Adjourn |
|
